FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential
- PMID: 20215979
- DOI: 10.1097/MNM.0b013e32833800e7
FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential
Abstract
Objective: We retrospectively evaluated the relationships between primary tumor F-fluorodeoxyglucose (FDG) uptake measured as the maximum standardized uptake value (SUV(max)) and local extension, and nodal or distant metastasis in patients with cervical cancer on pretreatment FDG positron emission tomography-computed tomography (PET-CT).
Methods: Forty-three patients (mean age, 55.14 years; range, 34-90 years) with cervical cancer who underwent FDG PET-CT scans for staging before the initiation of treatment were included in the study. Primary tumor SUV(max) was calculated; clinical tumor stages, presence of local extension, sites of lymph node and distant organ metastases were recorded. The patients were divided into low and high SUV groups by using the median primary tumor SUV(max). The low SUV group consisted of 21 patients with SUV(max) less than 13.5, the high SUV group consisted of 22 patients with SUV(max) > or = 13.5. Their data were compared statistically.
Results: The average SUV(max) was 9.6+/-2.6 and 19.9+/-4.9 in the low and high SUV groups, respectively. In the low SUV group, six patients (29%) had a local extension, eight (38%) had pelvic and/or para-aortic lymph node metastasis, and one had distant organ metastasis (4.7%). In the high SUV group, 10 patients (45%) had a local extension, 16 (73%) had pelvic and/or para-aortic lymph node metastasis, and two (9%) had distant organ metastases. There was a significant difference in the lymph node metastasis rate between the two groups (P<0.05), but differences in local extension and distant organ metastasis were not statistically significant (P>0.05). In addition, there was a moderate correlation between SUV(max) and clinical tumor stages (r=0.40, P=0.0075).
Conclusion: Higher primary tumor FDG uptake predicts higher nodal metastatic potential in cervical cancer patients. Patients with higher SUV(max) in cervical tumor may need a close follow-up because of their higher metastatic potential.
Similar articles
-
Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.Cancer. 2010 Mar 15;116(6):1469-75. doi: 10.1002/cncr.24972. Cancer. 2010. PMID: 20108309
-
FDG PET-CT in non-small cell lung cancer: relationship between primary tumor FDG uptake and extensional or metastatic potential.Asian Pac J Cancer Prev. 2013;14(5):2925-9. doi: 10.7314/apjcp.2013.14.5.2925. Asian Pac J Cancer Prev. 2013. PMID: 23803055
-
The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.Cancer. 2007 Oct 15;110(8):1738-44. doi: 10.1002/cncr.22974. Cancer. 2007. PMID: 17786947
-
Imaging evaluation of para-aortic lymph nodes in cervical cancer.Acta Radiol. 2023 Sep;64(9):2611-2617. doi: 10.1177/02841851231179178. Epub 2023 Jun 15. Acta Radiol. 2023. PMID: 37321631 Review.
-
The role of F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) in the screening of cervical cancer: a literature review.Cell Biochem Biophys. 2014 Jun;69(2):197-201. doi: 10.1007/s12013-013-9788-0. Cell Biochem Biophys. 2014. PMID: 24272282 Review.
Cited by
-
The Utility of 18F-FDG-PET-CT Metabolic Parameters in Evaluating the Primary Tumor Aggressiveness and Lymph Node Metastasis of Nasopharyngeal Carcinoma.Clin Med Insights Oncol. 2024 Feb 5;18:11795549231225419. doi: 10.1177/11795549231225419. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 38322667 Free PMC article.
-
[F18]FDG PET/CT-Derived Metabolic and Volumetric Biomarkers Can Predict Response to Treatment in Locally Advanced Cervical Cancer Patients.Cancers (Basel). 2022 Sep 8;14(18):4382. doi: 10.3390/cancers14184382. Cancers (Basel). 2022. PMID: 36139543 Free PMC article.
-
Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.PLoS One. 2015 Sep 14;10(9):e0137743. doi: 10.1371/journal.pone.0137743. eCollection 2015. PLoS One. 2015. PMID: 26368542 Free PMC article. Clinical Trial.
-
Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer.BMC Cancer. 2022 Jul 23;22(1):810. doi: 10.1186/s12885-022-09785-w. BMC Cancer. 2022. PMID: 35870900 Free PMC article.
-
Quantitative PET Imaging and Clinical Parameters as Predictive Factors for Patients With Cervical Carcinoma: Implications of a Prediction Model Generated Using Multi-Objective Support Vector Machine Learning.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820983804. doi: 10.1177/1533033820983804. Technol Cancer Res Treat. 2020. PMID: 33357081 Free PMC article.